The national independent specialty pharmacy DirectRx has joined the COPD Foundation’s Corporate Social Responsibility program to help support patients with […]
Genetic risk for asthma comes from changes in airway cells, study finds — ScienceDaily
A significant amount of genetic risk for asthma is likely mediated through altered gene expression within the airway epithelium. That […]
Will we have effective antibiotics in our future?
Posted on May 05, 2022 | This article was written by Jamie Sullivan, MPH, and COPD Advocate. At some point in […]
Why are people with allergic asthma less susceptible to severe COVID? — ScienceDaily
The vast majority of people infected with the omicron variant of SARS-CoV-2 experience mild cold-like symptoms, moderate flu-like symptoms, or […]
Plain Language Summaries for Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation Articles in Volume 9 Issue 2
Posted on May 17, 2022 | This article was written by Cathy Gray Carlomagno, BS Articles recently published in Volume 9, […]
Findings shine light on underpinnings of COPD, pave new direction for future research on treatments — ScienceDaily
A new type of cell that resides deep within human lungs and may play a key role in human lung […]
Exacerbations: What to Expect When You Call 9-1-1
Posted on June 14, 2022 | This article was written by Stephanie Williams, BS, RRT. Have you ever had to call […]
Dupixent found to prevent COPD exacerbations in Phase 3 trial | Chronic lung disease is 7th indication to show positive results
Dupixent (dupilumab) — a medication initially approved for exzema — was found to significantly reduce the number of disease exacerbations […]
New tool better predicts COPD risk for people of non-European ancestry — ScienceDaily
UVA Health researchers and their collaborators have developed a better way to predict the risk of chronic obstructive pulmonary disease […]